A
$ Value
$0
Shares
20,338
Price
$0
Filed
May 28
Insider
Name
VON ESCHENBACH ANDREW C.
Title
—
CIK
0001536529
Roles
Director
Transaction Details
Transaction Date
2025-05-27
Code
A
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
62,086
Footnotes
Reflects the annual grant of restricted share units ("RSUs") to non-employee directors under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan, as amended and restated. Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation. The RSUs are scheduled to vest immediately prior to the next annual meeting of shareholders.
Filing Info
VON ESCHENBACH ANDREW C.'s History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-02-27 | BLCO | ▲ | $80K ★ |
| 2026-02-27 | BLCO | A | $0 |
| 2025-05-27 | BLCO | A | $0 |
| 2025-05-02 | BLCO | ▲ | $20K |
Other Insiders at BLCO (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| COLLIS STEVEN H | $267K | — | 2026-02-23 |
| VON ESCHENBACH ANDREW C. | $80K | — | 2026-02-27 |
| Ross Thomas W. Sr. | $80K | — | 2026-03-03 |
| ROBERTSON RUSSEL C | $79K | — | 2026-02-20 |
| Alfonso Eduardo | $77K | — | 2026-03-02 |
| Ling Karen | $71K | — | 2026-02-19 |
|
SAUNDERS BRENT L
CEO and Chairman of the Board
|
— | — | 2026-02-27 |
| Paulson John | — | — | 2026-02-19 |
|
Eldessouky Sam
EVP and CFO
|
— | — | 2026-02-27 |
|
Bailey A Robert D
EVP & Chief Legal Officer
|
— | — | 2026-02-27 |
|
Munsch Frederick
SVP, Controller and CAO
|
— | — | 2026-02-27 |
|
Hashad Yehia
EVP of R&D and CMO
|
— | — | 2026-02-27 |
|
Stewart Andrew J.
President, GPIC
|
— | — | 2026-02-27 |
|
Bonnefoy Luc
President, Surgical
|
— | — | 2026-02-27 |